| Financial Year |
March 31 2023 |
| Monetary Funds |
307,149,924.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
116,503,259.87 |
| Accounts Receivable |
1,090,103,909.35 |
| Advances to Suppliers |
49,919,401.74 |
| Other Receivables |
16,812,915.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
19,406.19 |
| Inventories |
693,598,054.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
238,591.80 |
| Other Current Assets |
7,040,790.17 |
| Total Current Assets |
2,297,131,967.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
80,968.76 |
| Long-term Equity Investment |
207,134,081.89 |
| Investment Properties |
30,794,436.04 |
| Fixed Assetes |
454,813,301.72 |
| Under-construction Projects |
480,339,413.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
185,683,037.02 |
| R&D expenses |
-- |
| Goodwill |
30,239,649.76 |
| Long-Term Deferred and Prepaid Expenses |
1,951,190.48 |
| Deferred Income Tax Assets |
13,763,791.98 |
| Other Non-Current Assets |
23,102,961.50 |
| Sub-Total of Non-Current Assets |
1,439,412,886.89 |
| Total Assets |
3,736,544,854.57 |
| Short-Term Loans |
135,077,777.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
81,126,524.50 |
| Accounts Payable |
642,113,964.39 |
| Accounts Received In Advance |
95,135.20 |
| Employee Compensation Payable |
45,024,904.82 |
| Taxes Payable |
18,792,155.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
41,290,803.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,784,958.14 |
| Other Current Liabilities |
51,625,303.09 |
| Sub-Total of Current Liabilities |
1,095,098,364.16 |
| Long-term Loans |
248,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,619,105.06 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,051,063.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
284,903,520.10 |
| Total Liabilities |
1,380,001,884.26 |
| Paid-In Capital(Or Share Stock) |
590,760,499.00 |
| Capital Surplus |
95,562,730.39 |
| Surplus Reserve |
376,716,229.13 |
| LESS:Treasury Stock |
60,813,062.00 |
| Undistributed Profits |
1,292,517,444.61 |
| Minority Stockholder's Interest |
39,673,385.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,316,869,584.84 |
| Owner's Equity（Stockholder's Equity） |
2,356,542,970.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,736,544,854.57 |
